Adelaide Research & Scholarship: Search

Search

Results 21-30 of 109 (Search time: 0.006 seconds).

previous
1
2
3
4
5
6
...
11
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2016	The variable region of pneumococcal pathogenicity island 1 is responsible for unusually high virulence of a serotype 1 isolate	Harvey, R.; Trappetti, C.; Mahdi, L.; Wang, H.; McAllister, L.; Scalvini, A.; Paton, A.; Paton, J.; Pirofski, L.
	2013	Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases	Samaraweera, S.; O'Keefe, L.; Price, G.; Venter, D.; Richards, R.
	2013	BHLH-PAS proteins in cancer	Bersten, D.; Sullivan, A.; Peet, D.; Whitelaw, M.
	2013	Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles	Regev-Rudzki, N.; Wilson, D.; Carvalho, T.; Sisquella, X.; Coleman, B.; Rug, M.; Bursac, D.; Angrisano, F.; Gee, M.; Hill, A.; Baum, J.; Cowman, A.
	2014	Differential, dominant activation and inhibition of Notch signalling and APP cleavage by truncations of PSEN1 in human disease	Newman, M.; Wilson, L.; Verdile, G.; Lim, A.; Khan, I.; Nik, S.; Pursglove, S.; Chapman, G.; Martins, R.; Lardelli, M.
	2013	Phosphorylation of serine 779 in fibroblast growth factor receptor 1 and 2 by protein Kinase C(epsilon) regulates Ras/mitogen-activated protein kinase signaling and neuronal differentiation	Lonic, A.; Powell, J.; Kong, Y.; Thomas, D.; Holien, J.; Truong, N.; Parker, M.; Guthridge, M.
	2012	Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2	Cavell, B.; Alwi, S.; Donlevy, A.; Proud, C.; Packham, G.
	2014	Control of the translational machinery by amino acids	Proud, C.
	2014	SOX3 deletion in mouse and human Is associated with persistence of the craniopharyngeal canal	Alatzoglou, K.; Azriyanti, A.; Rogers, N.; Ryan, F.; Curry, N.; Noakes, C.; Bignell, P.; Hall, G.; Littooij, A.; Saunders, D.; Thomas, P.; Stewart, H.; Dattani, M.
	2015	Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment	Adomako, A.; Calvo, V.; Biran, N.; Osman, K.; Chari, A.; Paton, J.; Paton, A.; Moore, K.; Schewe, D.; Aguirre-Ghiso, J.